Biosig Technologies (BSGM) 1.3900 $BSGM
BioSig Achieves Important Technical Milestone
GlobeNewswire - Wed Aug 17, 7:00AM CDT
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP) information system, today announced its submission entitled "Enhanced Electrophysiology Recording System" will be presented on Friday, August 19, 2016 at the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2016). The presentation will be held in Pastoral 1 (Session FrCT8) at the Contemporary Resort in Orlando, Florida with a poster session to follow.
BioSig Technologies, Inc. Achieves Important Milestone
PR Newswire - Thu Aug 11, 12:17PM CDT
JACC: Clinical Electrophysiology Publication Highlights PURE EP's Unique Ability to Visualize High Frequency Signals
Medical Products' Earnings on Aug 10: PRGO, NVTR & BSGM
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 7:32AM CDT
The scorecard has so far exhibited a 4.1% year-over-year decline in second-quarter earnings on 0.9% lower revenues.
PRGO: 91.83 (+1.03), NVTR: 7.23 (-0.48)
BioSig Technologies' PURE EP System: Innovation for the $4 Billion Electrophysiology Market
PR Newswire - Thu Jul 28, 7:30AM CDT
By Malik Bahdari, Senior Staff Writer, Online Media Group, Inc.
BioSig Technologies to Present at the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society
GlobeNewswire - Tue Jun 07, 7:00AM CDT
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to assist electrophysiologists in making clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings and providing clarity of data which may be used in identifying ablation targets, today announced its submission entitled "Enhanced Electrophysiology Recording System" was accepted as a Late Breaking Research Paper for presentation at the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC2016).
BioSig Technologies to Present at the LD Micro Invitational
ACCESSWIRE - Thu Jun 02, 7:01AM CDT
LOS ANGELES, CA / ACCESSWIRE / June 2, 2016 / BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP System, a proprietary platform designed to improve the clinical outcomes of electrophysiology procedures, today announced that it will be presenting at the 6th annual LD Micro Invitational on June 7 at 2:00 PM PST.
OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
PR Newswire - Tue May 31, 5:49PM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the Marcum MicroCap Conference, taking place June 1-2nd at the Grand Hyatt New York. The Marcum MicroCap Conference, is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The Conference will feature presentations by CEOs and CFOs from various industry sectors, expert panels, and the opportunity to meet with management of presenting companies on a one-on-one basis.
LTEA: 5.90 (+0.23)
CEOLIVE.TV Announces New Interview With Gregory Cash, CEO of BioSig Technologies, Inc.
Marketwire Canada - Wed May 25, 10:00AM CDT
ORLANDO, FL--(Marketwired - May 25, 2016) - CEOLIVE, Inc., a provider of in-depth video interviews with public company CEOs (www.ceolive.tv), announced today that a new interview with Gregory Cash, CEO of BioSig Technologies, Inc. (OTCQB: BSGM), a Minnesota-based medical device company developing a proprietary technology platform designed to improve the rapidly growing multi-billion dollar electrophysiology (EP) marketplace, is now available on their website.
BioSig Technologies to Present at the Drexel Hamilton Micro Cap Investor Forum
GlobeNewswire - Thu May 05, 7:00AM CDT
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP System, a proprietary platform designed to improve the clinical outcomes of electrophysiology procedures, today announced that the company will present at the Drexel Hamilton Micro Cap Investor Forum held on May 12, 2016 at Drexel Hamilton's office at 77 Water Street, Second Floor in Lower Manhattan.
BioSig Technologies, Inc. (BSGM) Completes Private Placement
GlobeNewswire - Mon May 02, 7:00AM CDT
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP System, a proprietary platform designed to improve the clinical outcomes of electrophysiology procedures, today announced the Company closed a private placement with net proceeds of $4,504,524. Laidlaw & Co (UK) Ltd. in New York served as the sole placement agent.
BioSig Technologies to Attend Heart Rhythm Society's 37th Annual Scientific Sessions, May 4-7, 2016 in San Francisco, CA
GlobeNewswire - Wed Apr 27, 7:04AM CDT
BioSig Technologies, Inc. (OTCQB: BSGM) management will be attending the Heart Rhythm Society's 37th Annual Scientific Sessions from May 4-7 in San Francisco, CA. BioSig management recently announced an agreement with Minnetronix to initiate development of their PURE EP(TM) System, which addresses the global $4 billion electrophysiology marketplace. Additionally, the company established an advanced research program with Mayo Clinic in Rochester, Minnesota. BioSig management will be available to discuss these and other material updates at the event.
Interview with CEO of BioSig Technologies (BSGM): Seeking Better Outcomes for Patients with Complex Arrhythmias
ACCESSWIRE - Thu Apr 14, 9:05AM CDT
Seeking Better Outcomes for Patients with Complex Arrhythmias
BioSig Technologies Announces Advanced Research Program with Mayo Clinic
GlobeNewswire - Mon Mar 28, 7:00AM CDT
BioSig Technologies, Inc. (OTCQB: BSGM) today announced the establishment of an advanced research program with Dr. Samuel Asirvatham at Mayo Clinic in Rochester, Minnesota.
UPDATE -- OTCQX and OTCQB Companies to Present at 2016 Roth Conference
PR Newswire - Mon Mar 14, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the 28th Annual ROTH Conference, taking place March 13-16 at the Ritz-Carlton in Dana Point, CA. The ROTH Conference, hosted by ROTH Capital Partners, LLC, is one of the largest small-cap investment conferences in the U.S., featuring presentations by senior executives from hundreds of public and private companies in a wide variety of sectors.
MBVX: 4.82 (-0.33), VRAY: 2.75 (-0.25), DMPI: 6.53 (+0.24), CDXC: 3.77 (+0.01), EKSO: 4.05 (-0.02)
StockNewsNow.com Publishes New SNNLive Video Interview With BioSig Technologies, Inc.
Marketwired - Fri Mar 11, 7:30AM CST
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Video Interview with Ken Londoner, Executive Chairman of BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company that is developing a proprietary technology platform designed to improve the rapidly growing $4 billion electrophysiology (EP) marketplace, according to the Company's website (see here: www.BioSigTech.com). The video interview was recorded on Monday, February 22nd, 2016, at the SeeThruEquity & The Brewer Group's 2nd Annual Innovations Investor Conference 2016 in Miami, FL.
BioSig Technologies to Present at NobleCon12
GlobeNewswire - Tue Jan 12, 7:00AM CST
BioSig Technologies, Inc. (OTCQB: BSGM) today announced that its President & Chief Executive Officer, Greg Cash and VP Corporate Finance & Investor Relations, Brian McLaughlin will be participating at the NobleCon12 - Noble Financial Capital Markets' Twelfth Annual Investor Conference to be held January 17-20, 2016 in South Florida.
BioSig Technologies to Present at 8th Annual Biotech Showcase
GlobeNewswire - Wed Jan 06, 7:00AM CST
BioSig Technologies, Inc. (OTCQB: BSGM) today announced that it will be presenting at the 8th Annual Biotech Showcase(TM) to be held January 11-13, 2016 in San Francisco, California.
BioSig Achieves Important Technical Milestone
GlobeNewswire - Wed Aug 17, 7:00AM CDT
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP) information system, today announced its submission entitled "Enhanced Electrophysiology Recording System" will be presented on Friday, August 19, 2016 at the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2016). The presentation will be held in Pastoral 1 (Session FrCT8) at the Contemporary Resort in Orlando, Florida with a poster session to follow.
BioSig Technologies, Inc. Achieves Important Milestone
PR Newswire - Thu Aug 11, 12:17PM CDT
JACC: Clinical Electrophysiology Publication Highlights PURE EP's Unique Ability to Visualize High Frequency Signals
Medical Products' Earnings on Aug 10: PRGO, NVTR & BSGM
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 7:32AM CDT
The scorecard has so far exhibited a 4.1% year-over-year decline in second-quarter earnings on 0.9% lower revenues.
PRGO: 91.83 (+1.03), NVTR: 7.23 (-0.48)
BioSig Technologies' PURE EP System: Innovation for the $4 Billion Electrophysiology Market
PR Newswire - Thu Jul 28, 7:30AM CDT
By Malik Bahdari, Senior Staff Writer, Online Media Group, Inc.
BioSig Technologies to Present at the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society
GlobeNewswire - Tue Jun 07, 7:00AM CDT
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to assist electrophysiologists in making clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings and providing clarity of data which may be used in identifying ablation targets, today announced its submission entitled "Enhanced Electrophysiology Recording System" was accepted as a Late Breaking Research Paper for presentation at the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC2016).
BioSig Technologies to Present at the LD Micro Invitational
ACCESSWIRE - Thu Jun 02, 7:01AM CDT
LOS ANGELES, CA / ACCESSWIRE / June 2, 2016 / BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP System, a proprietary platform designed to improve the clinical outcomes of electrophysiology procedures, today announced that it will be presenting at the 6th annual LD Micro Invitational on June 7 at 2:00 PM PST.
OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
PR Newswire - Tue May 31, 5:49PM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the Marcum MicroCap Conference, taking place June 1-2nd at the Grand Hyatt New York. The Marcum MicroCap Conference, is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The Conference will feature presentations by CEOs and CFOs from various industry sectors, expert panels, and the opportunity to meet with management of presenting companies on a one-on-one basis.
LTEA: 5.90 (+0.23)
CEOLIVE.TV Announces New Interview With Gregory Cash, CEO of BioSig Technologies, Inc.
Marketwire Canada - Wed May 25, 10:00AM CDT
ORLANDO, FL--(Marketwired - May 25, 2016) - CEOLIVE, Inc., a provider of in-depth video interviews with public company CEOs (www.ceolive.tv), announced today that a new interview with Gregory Cash, CEO of BioSig Technologies, Inc. (OTCQB: BSGM), a Minnesota-based medical device company developing a proprietary technology platform designed to improve the rapidly growing multi-billion dollar electrophysiology (EP) marketplace, is now available on their website.
BioSig Technologies to Present at the Drexel Hamilton Micro Cap Investor Forum
GlobeNewswire - Thu May 05, 7:00AM CDT
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP System, a proprietary platform designed to improve the clinical outcomes of electrophysiology procedures, today announced that the company will present at the Drexel Hamilton Micro Cap Investor Forum held on May 12, 2016 at Drexel Hamilton's office at 77 Water Street, Second Floor in Lower Manhattan.
BioSig Technologies, Inc. (BSGM) Completes Private Placement
GlobeNewswire - Mon May 02, 7:00AM CDT
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP System, a proprietary platform designed to improve the clinical outcomes of electrophysiology procedures, today announced the Company closed a private placement with net proceeds of $4,504,524. Laidlaw & Co (UK) Ltd. in New York served as the sole placement agent.
BioSig Technologies to Attend Heart Rhythm Society's 37th Annual Scientific Sessions, May 4-7, 2016 in San Francisco, CA
GlobeNewswire - Wed Apr 27, 7:04AM CDT
BioSig Technologies, Inc. (OTCQB: BSGM) management will be attending the Heart Rhythm Society's 37th Annual Scientific Sessions from May 4-7 in San Francisco, CA. BioSig management recently announced an agreement with Minnetronix to initiate development of their PURE EP(TM) System, which addresses the global $4 billion electrophysiology marketplace. Additionally, the company established an advanced research program with Mayo Clinic in Rochester, Minnesota. BioSig management will be available to discuss these and other material updates at the event.
Interview with CEO of BioSig Technologies (BSGM): Seeking Better Outcomes for Patients with Complex Arrhythmias
ACCESSWIRE - Thu Apr 14, 9:05AM CDT
Seeking Better Outcomes for Patients with Complex Arrhythmias
BioSig Technologies Announces Advanced Research Program with Mayo Clinic
GlobeNewswire - Mon Mar 28, 7:00AM CDT
BioSig Technologies, Inc. (OTCQB: BSGM) today announced the establishment of an advanced research program with Dr. Samuel Asirvatham at Mayo Clinic in Rochester, Minnesota.
UPDATE -- OTCQX and OTCQB Companies to Present at 2016 Roth Conference
PR Newswire - Mon Mar 14, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the 28th Annual ROTH Conference, taking place March 13-16 at the Ritz-Carlton in Dana Point, CA. The ROTH Conference, hosted by ROTH Capital Partners, LLC, is one of the largest small-cap investment conferences in the U.S., featuring presentations by senior executives from hundreds of public and private companies in a wide variety of sectors.
MBVX: 4.82 (-0.33), VRAY: 2.75 (-0.25), DMPI: 6.53 (+0.24), CDXC: 3.77 (+0.01), EKSO: 4.05 (-0.02)
StockNewsNow.com Publishes New SNNLive Video Interview With BioSig Technologies, Inc.
Marketwired - Fri Mar 11, 7:30AM CST
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Video Interview with Ken Londoner, Executive Chairman of BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company that is developing a proprietary technology platform designed to improve the rapidly growing $4 billion electrophysiology (EP) marketplace, according to the Company's website (see here: www.BioSigTech.com). The video interview was recorded on Monday, February 22nd, 2016, at the SeeThruEquity & The Brewer Group's 2nd Annual Innovations Investor Conference 2016 in Miami, FL.
BioSig Technologies to Present at NobleCon12
GlobeNewswire - Tue Jan 12, 7:00AM CST
BioSig Technologies, Inc. (OTCQB: BSGM) today announced that its President & Chief Executive Officer, Greg Cash and VP Corporate Finance & Investor Relations, Brian McLaughlin will be participating at the NobleCon12 - Noble Financial Capital Markets' Twelfth Annual Investor Conference to be held January 17-20, 2016 in South Florida.
BioSig Technologies to Present at 8th Annual Biotech Showcase
GlobeNewswire - Wed Jan 06, 7:00AM CST
BioSig Technologies, Inc. (OTCQB: BSGM) today announced that it will be presenting at the 8th Annual Biotech Showcase(TM) to be held January 11-13, 2016 in San Francisco, California.
